The LRRK2 Gly2385Arg variant is associated with Parkinson’s disease: genetic and functional evidence
- 30 September 2006
- journal article
- research article
- Published by Springer Nature in Human Genetics
- Vol. 120 (6) , 857-863
- https://doi.org/10.1007/s00439-006-0268-0
Abstract
Evidence of LRRK2 haplotypes associated with Parkinson’s disease (PD) risk was recently found in the Chinese population from Singapore, and a common LRRK2 missense variant, Gly2385Arg, was independently detected as a putative risk factor for PD in the Chinese population from Taiwan. To test the association between the Gly2385Arg variant in a large case-control sample of Chinese ethnicity from Singapore, and to perform functional studies of the wild type and Gly2385Arg LRRK2 protein in human cell lines. In a case-control study involving 989 Chinese subjects, the frequency of the heterozygous Gly2385Arg genotype was higher in PD compared to controls (7.3 vs. 3.6%, odds ratio = 2.1, 95% CI: 1.1–3.9, P = 0.014); these values yield an estimated population attributable risk (PAR) of ∼4%. In a multivariate logistic regression analysis with the disease group (PD vs. controls) as the dependent variable and the genotype as an independent factor with adjustments made for the effect of age and gender, the heterozygous Gly2385Arg genotype remained associated with an increased risk of PD compared to wild type genotype (odds ratio = 2.67, 95% CI: 1.43–4.99, P = 0.002). The glycine at position 2385 is a candidate site for N-myristoylation, and the Gly2385Arg variant replaces the hydrophobic glycine with the hydrophilic arginine, and increases the net positive charge of the LRRK2 WD40 domain. In transfection studies, we demonstrated that both the wild type and Gly2385Arg variant LRRK2 protein localize to the cytoplasm and form aggregates. However, under condition of oxidative stress, the Gly2385Arg variant was more toxic and associated with a higher rate of apoptosis. Our study lends support to the contention that the Gly2385Arg is a common risk factor for PD in the Chinese population. Our bioinformatics and in-vitro studies also suggest that the Gly2385Arg variant is biologically relevant and it might act through pro-apoptotic mechanisms.Keywords
This publication has 31 references indexed in Scilit:
- Lack of G2019S LRRK2 mutation in a cohort of Taiwanese with sporadic Parkinson's diseaseMovement Disorders, 2006
- LRRK2 in Parkinson's disease: protein domains and functional insightsTrends in Neurosciences, 2006
- A common missense variant in the LRRK2 gene, Gly2385Arg, associated with Parkinson’s disease risk in Taiwanneurogenetics, 2006
- Comprehensive analysis of the LRRK2 gene in sixty families with Parkinson's diseaseEuropean Journal of Human Genetics, 2005
- Comprehensive evaluation of common genetic variation within LRRK2 reveals evidence for association with sporadic Parkinson's diseaseHuman Molecular Genetics, 2005
- Common variants of LRRK2 are not associated with sporadic Parkinson's diseaseAnnals of Neurology, 2005
- Testing association between LRRK2 and Parkinson's disease and investigating linkage disequilibriumJournal of Medical Genetics, 2005
- The G6055A (G2019S) mutation in LRRK2 is frequent in both early and late onset Parkinson's disease and originates from a common ancestorJournal of Medical Genetics, 2005
- A common LRRK2 mutation in idiopathic Parkinson's diseaseThe Lancet, 2005
- Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.Journal of Neurology, Neurosurgery & Psychiatry, 1992